Free tool
Oncology stocks
We cover 24 companies grouped under the Oncology theme. The median market value in the group is $115.60M. Across the group, the median move over the past trading day is +1.08%. 96% of the 24 with a 200-day average trade above it. Price change over the past year runs from −24.8% to +396.0% across the middle 80 percent of the group, with a median of +37.8%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
24 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| 0SZI.L | Corbus Pharmaceuticals Holdings, Inc. | $11.20 | +4.38% | +42.55% | +9.60% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| 0LOV.L | Verastem, Inc. | $7.15 | +3.62% | −1.79% | −19.93% |
| 0XOD.L | UroGen Pharma Ltd. | $46.18 | −1.66% | +104.45% | +136.88% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| 0QXX.L | Molecular Partners AG | 3.51 CHF | +2.33% | +3.54% | +17.00% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| 4583.T | Chiome Bioscience Inc. | 86.00 JPY | +26.47% | −19.63% | −36.76% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| 0NWK.L | Valerio Therapeutics Société anonyme | 0.86 EUR | +8.09% | +418.18% | +1279.03% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.